Sfbc (NASDAQ:SFCC)
Historical Stock Chart
From Jul 2019 to Jul 2024
Notice is hereby given that a class action has been
commenced in the United States District Court for the Southern
District of Florida on behalf of all persons who purchased the
publicly traded securities of SFBC International, Inc. (NASDAQ:SFCC)
("SFBC" or the "Company") between February 17, 2004 and December 15,
2005, inclusive (the "Class Period"). A copy of the complaint is
available from the Court, or call (305) 357-9010.
Hanzman & Criden has substantial experience representing employees
who suffered losses from purchases of their employer's stock in their
401 k plan. If you bought SFBC's stock through your SFBC retirement
account and have information or would like to learn more about these
claims, please contact us.
The complaint alleges that defendants violated federal securities
laws by issuing a series of materially false statements concerning
SFBC's business condition. Specifically, defendants touted the
Company's strong revenue, earnings, and its ability to outperform
competitors and obtain large contracts from drug companies, because of
the large numbers of participants its facilities could handle, and its
ability to quickly recruit participants for drug trails. SFBC's
financial success, however, was the result of business practices that
were improper and reckless, and if discovered, would cause the Company
to lose its credibility for accurate drug testing, and thus lose
customers, expose the Company to fines and possible lawsuits from
victims of faulty drugs, and face heavy regulation such that its
ability to outperform competitors and quickly recruit large groups of
participants could no longer be sustained.
When news of SFBC's improper business practices was revealed to
the market beginning on November 2, 2005, through the end of the Class
Period on December 15, 2005, the Company's stock price fell more than
60% from $41.49 to $15.78.
If you are a member of the class, you may, no later than March 6,
2006, request that the Court appoint you as lead plaintiff. A lead
plaintiff is a representative party that acts on behalf of other class
members in directing the litigation. In order to be appointed lead
plaintiff, the Court must determine that the class member's claim is
typical of the claims of other class members, and that the class
member will adequately represent the class. Under certain
circumstances, one or more class members may together serve as "lead
plaintiff." Your ability to share in any recovery is not, however,
affected by the decision whether or not to serve as a lead plaintiff.
You may retain Hanzman & Criden, or other counsel of your choice, to
serve as your counsel in this action. Hanzman & Criden has litigated
many class actions for violations of securities laws in federal courts
over the past 20 years and has obtained court approval of substantial
settlements on numerous occasions. Hanzman & Criden maintains its
offices in Miami, Florida.
If you wish to discuss this action or have any questions
concerning this notice or your rights or interests with respect to
these matters, please contact Kevin Love at Hanzman & Criden by e-mail
at klove@hanzmancriden.com or by calling (305) 357-9000.